Buradasınız

ADENOZİN DEAMİNAZ ENZİMİNİN KİNETİK DAVRANIŞI ÜZERİNE ZERDEÇAL (CURCUMA LONGA) EKSTRESİNİN ETKİLERİNİN ARAŞTIRILMASI

INVESTIGATION OF THE EFFECTS OF AQUOEUS TURMERIC (CURCUMA LONGA) EXTRACT ON KINETIC BEHAVIOR OF ADENOSINE DEAMINASE ENZYME

Journal Name:

Publication Year:

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
In this study, adenosine deaminase enzyme which plays an important role in cancer metabolism was isolated and partly purificated from cattle liver, and its kinetic properties were established with and without turmeric extract. V max and Km values of ADA enzyme were found to be 0.80 absorbance unit (as specific activity 40 mIU/g protein) and 100 mM respectively by using Michaelis Menten and Lineweaver Burk graphs drawn in the studies without inhibitor. In the Michaelis Menten and Lineweaver Burk graphs drawn with two different concentrations of Curcuma Longa extract, Km value was found to be 100 mM at both concentrations. V max value was found to be 0.5 (25 mIU/g protein) at the 10 % turmeric concentration,but it was 0.3 (15 mIU/g protein) at 20 % turmeric concentration. These results show that turmeric constituents inhibit ADA enzyme non competetively. This kind of inhibition of ADA enzyme by turmeric extract might be one of the mechanisms contributed to anti cancer potency of curcuma longa.
Abstract (Original Language): 
Bu çalışmada, kanser metabolizmasının kilit enzimlerinden biri olan adenozin deaminaz (ADA) sığır karaciğerinden izole edilerek kısmen saflaştırılmış, kinetik özellikleri incelenmiş ve enzimin kinetik davranışı üzerine zerdeçal ekstresinin etkileri araştırılmıştır. ADA enziminin inhibitörsüz şartlarda çizilen Michaelis Menten ve Lineweaver Burk grafiklerinde V max değeri absorbans olarak 0,8 (spesifik aktivite olarak 40 mIU/g protein), Km değeri 100 mM olarak tespit edilmiştir. Zerdeçal ekstresinin iki farklı konsantrasyonunda çizilen Michaelis Menten ve Lineweaver Burk grafiklerinde ise her iki durum için Km değeri 100 mM olarak, V max değerleri ise % 10 zerdeçal konsantrasyonunda 0,5 (25 mIU/g protein), % 20 zerdeçal konsantrasyonunda ise 0,3 (15 mIU/g protein) olarak bulunmuştur. Bu sonuçlar zerdeçal bileşenlerinin ADA enzimini non-kompetetif türde inhibe ettiğini göstermektedir. ADA enziminin zerdeçal tarafından bu şekilde inhibisyonu, zerdeçalın anti kanser özelliklerine katkı sağlayan mekanizmalardan biri olabilir.
759
765

REFERENCES

References: 

1. Gordon M. Cragg, David J., Newman Plants as a source of anti-cancer agents, Journal of Ethnopharmacology, Volume 100, Issues 1–2, 72–79, 22 August 2005.
2. Anand, P., Sundaram, C., Jhurani, S.; Kunnumakkara, A.B., Aggarwal, B.B. Curcumin and cancer: An “old-age” disease with an “age-old” solution, Cancer Lett., 267 (1), 133-164, 2008.
3. Kunnumakkara, A.B.; Anand, P.; Aggarwal, B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins, Cancer Lett., 269 (2), 199-225, 2008.
Adenozin Deaminaz Enziminin Kinetik Davranışı Üzerine Zerdeçal (Curcuma Longa) Ekstresinin... Z. E. Durak
Gazi Üniv. Müh. Mim. Fak. Der. Cilt 28, No 4, 2013 765
4. Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer potential of curcumin: preclinical and clinical studies, Anticancer Res., 23 (1A), 363-398, 2003.
5. Duvoix, A.; Blasius, R.; Delhalle, S.; Schnekenburger, M.; Morceau, F.; Henry, E.; Dicato, M.; Diederich, M. Chemopreventive and therapeutic effects of curcumin, Cancer Lett., 223 (2), 181-190, 2005.
6. Aggarwal, B.B. The past, present and future of multi-targeted cancer treatment “Naturally”: Food for thought. Cancer Lett., 269 (2), 187-188, 2008.
7. GuptaS., Prostate cancer chemoprevention: Current status and future prospects, Toxicol Appl. Pharmacol., 224 (3), 369-376, 2007.
8. Sandur, S.K.; Pandey, M.K.; Sung, B.; Ahn, K.S.; Murakami, A.; Sethi, G.; Limtrakul, P.; Badmaev, V.; Aggarwal, B.B. Curcumin, demethoxycurcumin, bisdemothoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism, Carcinogenesis, 8 (8), 1765-1773, 2007.
9. W. K. Jordan, R. March, O. B. Houchin & E. Popp, J. Neurochem. 4, 170, 1959.
10. T. G. Brady & C. I. O’ Donovan, Biochem. J. 80, 17, 1961.
11. B. Galanti & G. Giusti, Minerva Med. 59-II, 5867, 1968.
12. G. Giusti, Pol. Arch. Med. Wewn. 44, 524, 1970.
13. Goldberg, DM. : Serum Adenosine Deaminase in the Differential Diagnosis of Jaundice, Brit Med J. 1 : 353-355, 1995.
14. Solomon, JB., Constitutive Enzymes of the; Devoloping Chick Embryo:Adenosine Deaminase, Biochem J., 75 : 278-284, 1959.
15. Daddona, P.E., Orkın,S.H., Shewach,D.S and Kelley, W.N., cDNA and Aminoacid Squence of Human Adenosine Deaminase, Ann.N.Y. Acad.Sci., 451:238-244, 1985.
16. Wilson, D.K., Rudolph, F.B., Quiocho, F.A.: Atomic Structure of Adenosine Deaminase Complexed with Transition-State Analge: Understanding Catalysis and Imunodefiency Mutations, Science, 252:1278-1284, 1991.
17. Sutton R, Rockett B, Swindells P., Chemistry for the Life Sciences, 1st ed., London, 2000.
18. Lowry O, Rosenbrough N, Farr L, Randall R. Protein measurement with folin phenol reagent, J Biol Chem., 182: 265-275, 1951.
19. Guisti G. Adenosine Deaminase, In: Methods of Enzymatic Analysis, 2nd Ed. Bergmeyer ,HV. New York, Academic Pres, 1092-1099, 1974.
20. Desai, Avni G.; Qazi, Ghulam N.; Ganju, Ramesh K.; El-Tamer, Mahmoud; Singh, Jaswant; Saxena, Ajit K.; Bedi, Yashbir S.; Taneja, Subhash C.; Bhat, Hari K. Medicinal Plants and Cancer Chemoprevention, Current Drug Metabolism, Volume 9, Number 7, 581-591(11), 2008.
21. Wu-Yang Huanga, Yi-Zhong Caia & Yanbo Zhangb Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention, Nutrition and Cancer Volume 62, Issue 1, 1-20, 2009.
22. Durak Z.E., Gürü M., Investigation of The Effects of Aquoeus Turmeric (Curcuma Longa) Extract on Kinetic Behaviour of Adenosine Deaminase Enzyme, Journal of The Faculty of Engineering and Architecture of Gazi University, Volume 28, No 1, 209-215, 2013.
23. Aggarwal, B.B. The past, present and future of multi-targeted cancer treatment “Naturally”: Food for thought, Cancer Lett., 269 (2), 187-188, 2008.
24. Gupta, S. Prostate cancer chemoprevention: Current status and future prospects, Toxicol. Appl. Pharmacol., 224 (3), 369-376, 2007.
25. Anto, R.J.; George, J.; Babu, K.V.; Rajasekharan, K.N.; Kuttan, R. Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids, Mutat. Res., 370 (2), 127-131, 1996.
26. Rao, K.V.K.; Schwartz, SA.; Nair, HK.; Aalinkeel, R.; Mahajan, S.; Chawda, R.; Nair, MN. Plant derived products as a source of cellular growth inhibitory phytochemicals on PC-3M, DU-145 and LNCaP prostate cancer cell lines, Curr. Sci., 87: 1585- 15888, 2004.
27. Glazer R, Adenosine deaminase inhibitors: Their role in chemotherapy and immunosuppression, Cancer Chemotherapy and Pharmacology, 4, 4, 227-235, 1980.

Thank you for copying data from http://www.arastirmax.com